Downside and the Floor

Downside and the Floor

The Trade Desk has no funded debt, $1.41 billion of cash and securities, and a revolver its bank syndicate enlarged and repriced downward in April 2026. On a frozen cost base, revenue would have to fall 41% before adjusted EBITDA reached zero. The cost base has never been frozen: in the one quarter revenue ever fell, operating expenses rose 21%.

What has to go wrong, and by how much

FY2025 revenue was $2,896.3 million against total operating expenses of $2,307.0 million, leaving $589.3 million of operating income [1]. Of that expense base, $490.6 million was stock-based compensation [2] and $115.8 million was depreciation and amortisation [3]. Strip both out and the cash the company actually paid to run itself in FY2025 was $1,700.6 million — 59% of revenue.

That number sets the boundary conditions. Holding every FY2025 cost dollar flat, three thresholds follow arithmetically: GAAP operating income reaches zero at $2,307 million of revenue, 20.4% below FY2025; adjusted EBITDA covers FY2025's $209.8 million of capital expenditure and capitalised software at $1,910 million, 34.0% below [4]; and adjusted EBITDA reaches zero at $1,701 million, 41.3% below.

Sources: FY2025 cost base and capital expenditure per the FY2025 Form 10-K [5] [6]; thresholds derived; FY2026 and FY2027 estimates from consensus data, as reported.

The lowest FY2027 revenue estimate carried in the consensus set is $2,629 million — 9.2% below FY2025 actual and 17.3% below the FY2026 consensus of $3,177 million, against an FY2027 average of $3,482 million. The most pessimistic published forecast of this business therefore sits roughly half the distance to the GAAP breakeven line and less than a quarter of the way to the adjusted EBITDA line. A frozen cost base bounds the downside rather than forecasting it, and the bound is wide: 20.4% of revenue decline to GAAP breakeven, 41.3% to zero adjusted EBITDA.

The quarter revenue fell

There is one precedent in the public record. In the June 2020 quarter revenue fell to $139.4 million from $159.9 million, down 12.9%, and a $31.9 million operating profit became a $15.8 million operating loss. Operating expenses that quarter were $155.1 million against $128.0 million a year earlier — up 21% while revenue fell 13%.

Source: quarterly figures as reported in company filings; operating expenses derived as revenue less operating income. The annual context is in the FY2021 Form 10-K [7].

The recovery came from revenue, not from cost action. September-quarter revenue rebounded 32% year over year, and the full year still grew: revenue of $836.0 million, up 26%, and operating income of $144.2 million, up 29%, on operating expenses that themselves rose 26% [8]. The company later described the episode in its risk factors as "the initial decline in revenue in response to the COVID-19 pandemic" [9].

The counter-fact to reading that as a template: the 2020 company was roughly a fifth of today's size, the shock lasted a single quarter, and cutting into a two-month advertising pause would have been the wrong decision. What the episode does establish is that the observed elasticity of this cost base to a revenue decline, over one quarter, was zero.

Two years out, at the low end

The question the thresholds leave open is what management does with the cost base if revenue disappoints for longer. The grid below holds the FY2025 cost structure and grows it at three rates through FY2027, against three revenue outcomes.

Source: derived from the FY2025 cost base — total operating expenses of $2,307.0 million, of which $490.6 million stock compensation and $115.8 million depreciation and amortisation [10] [11] [12] — grown at the stated rates; revenue cases from consensus estimates, as reported. Figures in $ millions.

At the street's lowest FY2027 revenue estimate with costs frozen, the business still earns $928 million of adjusted EBITDA and $322 million of GAAP operating income; the $6.74 billion enterprise value at $17.29 — 471.0 million shares less $1.41 billion of net cash [13] — is 7.3 times that adjusted EBITDA. A cost base compounding at 12% a year instead produces $496 million of adjusted EBITDA and a $265 million GAAP operating loss on the same revenue. Adjusted EBITDA never turns negative anywhere in the grid; GAAP operating income turns negative in one cell and reaches breakeven in another. The difference between the two measures is stock compensation, which does not shrink when revenue does — and at $17.29 a share, holding a given team costs more shares than it did.

The current run rate sits at the wrong end of that range. First-quarter FY2026 operating expenses were $622 million, up 11%, and $513 million excluding stock compensation, up 18%, against revenue growth of 11.8% [14] [15]. Management's stated plan for the rest of the year is headcount growth below revenue growth, and the finance chief describes the model as one in which "we generate strong cash flow and can maintain significant flexibility in how we pace our investments and expenses" [16]. That flexibility is asserted rather than demonstrated; the FY2026 margin commitment examined in Financials and Estimates is the first place it becomes checkable.

The tax that has not been paid yet

Free cash flow is the denominator most of this report's valuation work rests on, and one input to it has been running below its own accrual for three years. FY2025 pretax income was $658.8 million and the total provision $215.5 million — a 32.7% effective rate — but the current portion of that provision was only $42.7 million, against $189.6 million in FY2024, with $172.7 million booked as deferred [17].

Source: FY2025 Form 10-K, Note 11 Income Taxes [18] [19].

Cash income taxes paid were $150.1 million in FY2025, $158.6 million in FY2024 and $151.9 million in FY2023 — essentially unchanged while pretax income went from $268 million to $659 million [20]. The cash tax rate on pretax income fell from 57% to 23% across those three years.

What financed the gap is now largely spent. Net deferred tax assets fell from $230.2 million to $55.7 million during FY2025, with the capitalised software development component collapsing from $181.9 million to $6.8 million [21], because the One Big Beautiful Bill Act allowed immediate deduction of previously capitalised domestic research costs; the company recognised $175 million as an income-tax receivable against that election [22]. Part of that receivable was collected in the March 2026 quarter, and the provision that quarter rose $14 million on tax detriments from vesting employee stock awards, taking the quarterly effective rate to 49% [23] [24].

FY2026 cash taxes are therefore flattered by a one-off refund, and the shield behind them has shrunk to $55.7 million. On FY2025's pretax income at FY2025's book rate, the tax bill is about $215 million rather than the $150 million paid — roughly $65 million a year of cash that the recent free-cash-flow record did not have to find. Against FY2025 free cash flow of $783 million on the company's own definition — operating cash flow of $992.7 million less $197.0 million of capital expenditure and $12.8 million of capitalised software [25] — that is an 8% haircut before any revenue assumption is made. The counter-fact is that the effective rate itself is inflated by non-deductible stock compensation, which added 7.1 points in FY2025 [26] — if the share price recovers, that penalty shrinks.

What does not flex

At March 31, 2026 non-cancelable contractual obligations totalled $1,115.9 million: $777.7 million of operating leases for offices and hosting facilities and $338.2 million of other commitments for hosting services, hardware, data providers and software, with $288.3 million of the total falling due in the remainder of 2026 [27]. At the December 2025 year end the lease ladder ran to $795.2 million undiscounted on a 5.5-year weighted-average term, of which $291.0 million related to leases not yet commenced [28]. In January 2026 the company added $92 million of non-cancelable cloud hosting and data commitments running to 2028 [29].

Total lease cost has risen from $61.5 million in FY2023 to $75.4 million in FY2024 to $94.4 million in FY2025 [30]. The data-centre build described in Cash and Share Count as a capital-expenditure step-up also arrives as a multi-year lease obligation, and leases signed for capacity not yet commenced are the part of the cost base least responsive to a revenue disappointment.

The floor

Sources: cash of $878.4 million and short-term investments of $527.5 million with no drawn debt at March 31, 2026 [31]; the $750 million facility less $5 million of outstanding letters of credit [32] [33]; breakeven derived.

On April 14, 2026 — with the shares roughly 87% below their December 2024 high — a syndicate led by JPMorgan replaced the $450 million revolver that was due to mature that June [34] with a $750 million facility running to April 14, 2031, plus the right to add a further $750 million on additional lender commitments [35] [36]. The terms moved in the borrower's favour on every disclosed dimension: the SOFR margin grid narrowed to 1.125%–1.500% from 1.25%–2.25%, and the undrawn commitment fee to 0.125%–0.200% from 0.200%–0.350% [37] [38]. The leverage test is now struck on funded debt net of up to $250 million of unrestricted cash, where the old one was gross [39] [40].

The executed agreement is in the filing record, and its negative covenants run to six sections — non-guarantor subsidiary indebtedness, sale and leaseback transactions, fundamental changes, use of proceeds, liens, and outbound investment rules — under a single financial covenant, a total leverage ratio of 3.50 to 1.00 [41] [42]. The 2021 agreement it replaces listed negative covenants running from Section 8.01 to Section 8.26 [43], among them Section 8.10, Dividends, Redemptions, Distributions, which barred the company and its subsidiaries from paying dividends or repurchasing their own equity except through an enumerated list of permitted exceptions [44]. With nothing drawn, the leverage test is not binding, and the restriction on repurchases has gone; $327 million of buyback authorisation remained at March 31, 2026 [45].

The honest qualification is that the old facility matured in June 2026, so a refinancing was scheduled rather than opportunistic. The evidence is in the terms rather than in the fact of the deal: a larger facility, a maturity running to 2031, a narrower SOFR margin grid and a lower undrawn commitment fee. A lending syndicate repriced this credit cheaper, longer and larger while the equity market was marking the enterprise at 5.6 times FY2025 adjusted EBITDA, and it retained a lien on substantially all assets with release on investment-grade ratings [46].

Where the balance-sheet risk actually sits

The exposure is in the receivable book. Accounts receivable were $3.32 billion at March 2026 against an allowance for credit losses of $16.2 million — 0.49% of the gross, up from 0.32% three months earlier [47]. At December 2025 two clients each accounted for at least 10% and together for 30% of consolidated receivables, and two suppliers for 34% of payables [48]. Under sequential liability an agency is not liable to the company if its advertiser does not pay, while the company is "contractually required to pay advertising inventory and data suppliers within a negotiated period of time, regardless of whether our clients pay us on time, or at all" [49].

That is the one event that could consume a material share of the $1.41 billion of net cash in a short period, and it is the concentration risk documented in Share or Cycle arriving through the balance sheet rather than the income statement. Two facts cut against reading it as acute: the concentration measured on receivables fell over the year — three clients were 42% of the book at December 2024 against two at 30% a year later [50] — and the counterparties concerned are the largest agency holding companies in the industry, not marginal credits. The reserve of 0.49% is the company's own assessment that the book is good; it has never been tested by a holding-company failure.

What would change the read

The judgment here is that at $17.29 the equity is priced against an earnings question, not a survival question, and the record supports that: no funded debt, $1.41 billion of net cash, a five-year facility signed at improved terms, and 41 points of revenue decline between FY2025 and an adjusted-EBITDA loss. The fact that argues hardest the other way is the elasticity evidence — in the only quarter revenue has ever fallen, costs rose 21%, and in the most recent quarter cash costs grew 18% against 12% revenue growth.

That judgment is about the balance sheet. The growth half of the report's opening question is answered across the other chapters, and the pieces do not point the same way: the deceleration is a United States phenomenon on the recast geography, where international revenue is still compounding at a multiple of the domestic rate (US and International); video is still compounding while mobile contracts (CTV and Channel Mix); the rate lever that carried reported revenue past gross spend in FY2025 is real but has a visible end (Pricing and Take Rate); and the cost base has never contracted with revenue. Against the $6.74 billion enterprise value, an FY2027 outcome anywhere inside the street's own range — $2,629 million at the low end, $3,482 million on average — is worth 7.3 times adjusted EBITDA at the low estimate with costs frozen and 3.8 times at the average, or 13.6 and 5.0 times if costs compound at 12% a year. What stands behind those multiples is arithmetic rather than judgment: more than 20 points of revenue decline separate FY2025 from a GAAP operating loss on a frozen cost base and more than 40 from an adjusted-EBITDA loss, so an outcome at the low end of the street range costs the holder multiple compression rather than a funding problem. What none of it settles is whether the volume line has stopped decelerating; the thresholds size the downside, they do not date the recovery.

Four lines in the filings will show whether that read holds:

Platform operations as a share of revenue, in the MD&A results table — 21.4% in FY2025 [51] and 26.4% in the March 2026 quarter [52]. A third consecutive quarter above 25% alongside revenue growth below 10% would mark the cost base as structurally heavier, not cyclically so.

Cash paid for income taxes, net of refunds, in the supplemental cash-flow disclosure — $150.1 million in FY2025 [53]. An FY2026 figure materially above $215 million confirms the step-up; one near FY2025's level means the shield ran longer than the deferred-asset balance suggests.

Operating lease commitments in the contractual-obligations table — $777.7 million at March 2026 [54]. Further increases lock in fixed cost ahead of revenue that has not arrived.

The allowance for credit losses on the balance sheet — $16.2 million at March 2026 [55]. A step change there is the earliest visible sign that the receivable concentration has stopped being theoretical.